On behalf of the Board of Cambium Bio Limited, I am pleased to invite you to the AnnualGeneral Meeting of Cambium Bio Limited. This meeting will be held in person at the offices of the Company located at 16 Goodhope St Paddington NSW 2021 on Tuesday 26th November 2024 at 11:00am (Sydney time).
The Company’s General Meeting will be held in person.
A copy of the Notice of Meeting was released to the ASX today, to view and download a copy of the Notice of Meeting please visit the following link on the Company’s website:
The items of business to be conducted at the 2024 Annual General Meeting are set out in the Notice of Meeting as the following Resolutions:
Resolution 1: Adoption of the Remuneration Report
Resolution 2: Re-election of a Director, Dr. Yu-Hung Sebastian Tseng
Resolution 3: Re-election of a Director, Terence A Watts
Resolution 4: Re-election of a Director, Dr. Edmund K Waller
Resolution 5: Re-election of a Director, ChiTai Chang
Resolution 6: Approval of additional placement capacity under Listing Rule 7.1A
Resolution 7: Approval to issue up to AUD$5,000,000 worth of Shares
The Notice of Meeting contains explanatory information regarding all items of business.
The Board recommends that shareholders vote in favour of all items of business.
Should any shareholder have any queries regarding their shareholding, or in respect of the Company’s GM, please contact Cambium Bio’s share registry, Link Market Services by phoning 1300 554 474 (within Australia) or +61 1300 554 474 (for shareholders located overseas).
You can also update your communication preferences to ensure you receive all future communication from the Company electronically, by updating your details online via https://investorcentre.linkgroup.com.
The Board of Cambium Bio looks forward to welcoming you to the Company’s General Meeting.